MENU
SER
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Serina Therapeutics (SER) Earnings Date & Reports

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more

A.I. Advisor
published Earnings

SER is expected to report earnings to fall 38.18% to -34 cents per share on November 18

Serina Therapeutics SER Stock Earnings Reports
Q3'26
Est.
$-0.34
Q2'26
Missed
by $0.09
The last earnings report on August 13 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 46.26K shares outstanding, the current market capitalization sits at 51.05M.